Faster EU Drug Assessment Pathway Takes Shape: Convergence With US Breakthrough Designation On the Cards
This article was originally published in SRA
Executive Summary
EU drug regulators are pressing on with plans to develop an early-stage innovative medicines designation-type scheme to support the development of and speed access to drugs that address major public health needs.